Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00294502 · ClinicalTrials.gov registry record · Phase 4
Antibiotic Lock Solutions in the Prevention of Catheter Related Bacteremia
A Phase 4 study, sponsored by Henry Ford Health System.
- Completed
- Registry status
- Phase 4
- Development phase
- 120
- Enrollment target
NCT00294502 is a Phase 4 study that has completed, run by Henry Ford Health System. The registered enrollment target is 120 participants.
The verdict
NCT00294502, a Phase 4 study, has completed, sponsored by Henry Ford Health System.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 120 participants
- Enrollment target
Study Summary
To study the efficacy of an antibacterial/anticoagulant solution instilled into the hemodialysis (HD) catheters after each treatment ("antibiotic lock solution - ALS") to prevent catheter related bacteremia (CRB) and to salvage catheters with established CRB.
Interventions
- DRUG Gentamycin/citrate, Minocycline/EDTA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2003-09 |
| Est. Completion | 2004-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00294502
The ClinicalTrials.gov registry entry for NCT00294502 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Gentamycin/citrate, Minocycline/EDTA is the first listed.
NCT00294502 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00294502 about?
NCT00294502 is a clinical study titled "Antibiotic Lock Solutions in the Prevention of Catheter Related Bacteremia". To study the efficacy of an antibacterial/anticoagulant solution instilled into the hemodialysis (HD) catheters after each treatment ("antibiotic lock solution - ALS") to prevent catheter related bacteremia (CRB) and to salvage catheters with established CRB.
What is the current status of trial NCT00294502?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 120 participants. The study started on 2003-09. Estimated completion is 2004-05.
What interventions are being tested in trial NCT00294502?
The interventions under investigation include: Gentamycin/citrate, Minocycline/EDTA (DRUG).
Who is sponsoring clinical trial NCT00294502?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.